Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Verrica Pharmaceuticals Announces Participation in the 42nd Annual Cowen Virtual Healthcare Conference
-
Verrica Pharmaceuticals Inc. (VRCA) Prices 2.034M Share Common Offering at $14.75/Sh
-
Verrica Announces Pricing of Public Offering of Common Stock
-
Verrica Announces Pricing of Public Offering of Common Stock
-
Verrica Pharmaceuticals Inc. (VRCA) to Offer Common Stock
-
Verrica Announces Proposed Public Offering of Common Stock
-
Verrica Announces Proposed Public Offering of Common Stock
-
Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
-
Verrica Pharmaceuticals Announces Participation in the Cowen 41st Annual Health Care Conference
-
Verrica Pharmaceuticals (VRCA) PT Lowered to $25 at Cowen Following CRL
-
Verrica Pharmaceuticals to Attend Several Upcoming Investor Conferences
-
Verrica Pharmaceuticals to Attend Several Upcoming Investor Conferences
-
Verrica Pharmaceuticals Announces Participation in the Cowen and Company 39th Annual Healthcare Conference
-
Verrica Pharmaceuticals Announces Participation in the Cowen and Company 39th Annual Healthcare Conference
-
Cowen Starts Verrica Pharmaceuticals (VRCA) at Outperform
-
Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering
-
Verrica Pharmaceuticals Inc. Announces Closing of Initial Public Offering
-
Verrica Pharmaceuticals (VRCA) IPO Opens 33%
-
Verrica Pharmaceuticals Inc. (VRCA) Prices 5M Share IPO at $15/Sh
-
Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering
-
Verrica Pharmaceuticals Inc. Announces Pricing of Initial Public Offering
